People
Toby Maher
Toby Maher is a published external PureTech collaborator and professor and director of interstitial lung disease at USC Keck School of Medicine. PureTech highlights his Phase II pirfenidone trial in unclassifiable interstitial lung disease. This is an external scientific affiliation.
Roles
PureTech Health
CurrentScientific Collaborator (external; published network)